As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...
Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis®, a suite of artificial intelligence (AI)-powered Software as Medical Devices (SaMDs) for early cancer ...
Benefits include reduced radiation exposure, fewer adverse reactions, higher image quality, and better detection of malignant features.
Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 different types of cancer from a single blood draw, while full-body MRI scans, ...
EVERY day without a dedicated PhilHealth Z Benefit Package for lung cancer means more Filipino families face delayed ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...
The Lung Cancer Diagnostics Market is set to expand from US$ 21.74 billion in 2025 to US$ 38.00 billion by 2033, growing at a ...
Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.
Patient advocates are calling for the immediate creation of a dedicated PhilHealth Z Benefit Package for lung cancer, warning that the absence of ...
Tempus AI (NasdaqGS:TEM) has launched a new AI-driven HRD-RNA algorithm aimed at improving cancer diagnostics. The company has entered a partnership with Median Technologies to bring advanced lung ...
West Yorkshire health leaders welcome new national cancer plan but warn delivery will be ‘crucial’ for families.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results